0001140361-17-033123.txt : 20170823 0001140361-17-033123.hdr.sgml : 20170823 20170823183333 ACCESSION NUMBER: 0001140361-17-033123 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170821 FILED AS OF DATE: 20170823 DATE AS OF CHANGE: 20170823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flaherty Keith T. CENTRAL INDEX KEY: 0001579310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36562 FILM NUMBER: 171047919 MAIL ADDRESS: STREET 1: 55 FRUIT STREET STREET 2: YAWKEY 9E CITY: BOSTON STATE: MA ZIP: 02114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Loxo Oncology, Inc. CENTRAL INDEX KEY: 0001581720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462996673 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 281 TRESSER BOULEVARD, 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 203-653-3880 MAIL ADDRESS: STREET 1: 281 TRESSER BOULEVARD, 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06901 4 1 doc1.xml FORM 4 X0306 4 2017-08-21 0 0001581720 Loxo Oncology, Inc. LOXO 0001579310 Flaherty Keith T. C/O LOXO ONCOLOGY, INC. 281 TRESSER BLVD, 9TH FLOOR STAMFORD CT 06901 1 0 0 0 Common Stock 2017-08-21 4 S 0 3800 71.9091 D 20432 D Common Stock 2017-08-21 4 S 0 3450 72.6460 D 16982 D The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 13, 2016. Represents the aggregate of sales effected on the same day at different prices. Represents the weighted average sales price per share. The shares sold at prices ranging from $71.32 to $72.31 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $72.325 to $73.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. /s/ Jennifer Burstein, by power of attorney 2017-08-23